Latest News & Features
Americas
As President-elect Donald Trump prepares for his second term, the life sciences industry is calling for predictability, finds Marisa Woutersen. 5 December 2024
Americas
Jury finds medical device company misappropriated secrets covering Insulet’s Omnipod l Insulet “extremely pleased” with verdict l Federal circuit overturned ban on EOFlow’s product in June. 5 December 2024
Americas
German biotech asks federal judge to reject Amgen’s efforts to narrow scope of a key patent in ongoing dispute | Patent relates to Lindis' cancer immunotherapy treatment | Lindis calls on court to uphold the broader interpretation and claims Amgen’s attempt to narrow is inconsistent with the patent's history. 3 December 2024
Europe
One-day event in London brings in-house counsel and private practitioners together | First sessions to kick off the day covered European Patent Office procedures, and in-house views on how the UPC is faring. 3 December 2024
Careers
Former EIP partner joins IP and technology practice | New London hire is known for high-stakes, cross-border patent litigation. 3 December 2024
Americas
New England Biolab contends plaintiff’s patents are invalid and cover “unpatentable natural processes”| Biomodal had accused rival of infringing several patents covering methods to detect and modify DNA methylatian—a key part of epigenetic research 28 November 2024
Americas
Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade Intelectual and Jeffrey Morton of Haynes and Boone. 28 November 2024
Americas
Wholesaler ‘bought nearly 17,000 bottles of fake Gilead drugs’ | US government says defendant sentenced in September should pay company for lost profits. 26 November 2024
Europe
European panel deals blow to a biotech company over human milk oligosaccharides used in infant formula | Patent opposed by giant Nestlé, FrieslandCampina, and Danisco questioning its inventive step. 26 November 2024
Asia
Agreement provides for €140 million in upfront and additional payments to Cytokinetics and up to €490 million in milestone payments, with tiered royalties on future sales | “Important regional deal” comes as Bayer’s new partner eyes US and European markets. 21 November 2024